By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after ...

Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster ...

“The medication comes with a patient information leaflet listing common side effects, including feeling sick, indigestion, ...

Projections show half of ten and 11-year-olds could be overweight or obese in some areas, with experts calling for urgent ...

Ecnoglutide is a GLP-1 receptor agonist, part of a growing class of drugs that help control blood sugar and reduce hunger.

More than one million people in the UK are already paying for the appetite-suppressing drug, from private clinics which ...

Majority of UK children will be overweight or obese in nine areas by 2035 - Nine worst affected areas predicted to see child ...

The NHS has just announced a major change made to Mounjaro access as 1,600,000 people are now expected to receive the weight ...

A global study has found that recycled polyethylene plastic can leach over 80 chemicals into water, disrupting hormone ...

The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...

The blockbuster weight loss drug, semaglutide, now has competition in orforglipron, which is just as safe as injectable ...